CTCX (CTCX)
Carmell Therapeutics Corporation
NASDAQ:CTCXHealthcare · Biotechnology
Mkt Cap-
Float14.74M
O/S-
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$1.91M
Net Income-$6.91M
Total Assets$2.37M
Free Cash Flow-$3.34M
Debt & Equity
Total Debt$310K
Total Equity-$5.87M
Shares Outstanding
Short Interest
Split History1 split
- 50:1Forward splitNov 15, 20041 share → 50
Balance Sheet Details
Assets$2.37M
Liabilities$8.23M
Accounts Receivable$37K
Accounts Payable$4.49M
Inventory$963K
PP&E (Net)$402K
Goodwill$0
Intangible Assets$15K
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Revenue | $1.91M | $50K | $0 | $0 | $0 |
| YoY Growth | 3701.4% | - | - | - | - |
| Cost of Revenue | $818K | $6K | $125K | $243K | $0 |
| Gross Profit | $1.09M | $44K | -$125K | -$243K | $0 |
| Gross Margin | 57.2% | 87.4% | - | - | - |
| Research and Development | $789K | $1.05M | $2.5M | $2.2M | $983K |
| Selling, General, and Administrative | $7.33M | $3.9M | $2.6M | $3.22M | $863K |
| Other | $0 | $83K | $0 | -$148K | $94K |
| Total Operating Expenses | $8.12M | $5.04M | $5.09M | $5.27M | $1.94M |
| Operating Income (EBIT) | -$7.11M | -$5M | -$5.22M | -$5.51M | -$467K |
| Operating Margin | -371.6% | -9933.8% | - | - | - |
| Interest Expense | -$18K | $49K | $889K | $3.75M | $2.5M |
| Interest Income | $0 | $0 | $0 | $2.25M | $8K |
| Other Income (Expense) | $239K | -$5.75M | -$10.99M | -$3.54M | $138K |
| Income Before Tax (EBT) | -$6.87M | -$10.75M | -$16.21M | -$9.05M | -$329K |
| Income Tax Expense | $36K | -$97K | $0 | $0 | $0 |
| Net Income | -$6.91M | -$10.37M | -$15.45M | -$9.05M | -$6.48M |
| Net Income Margin | -361.0% | -20605.5% | - | - | - |
| Supplementary Data | |||||
| EPS | -4.83 | -0.50 | -0.74 | -0.50 | -0.01 |
| Diluted EPS | -4.83 | -0.50 | -0.74 | -0.50 | -0.01 |
| Weighted Average OS | 1.43M | 20.91M | 20.77M | 19.77M | 19.77M |
| EBITDA | -$6.81M | -$10.5M | -$15.19M | -$5.06M | -$87K |
| EBITDA Margin | -355.9% | -20870.2% | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Assets | |||||
| Current Assets | |||||
| Cash and Cash Equivalents | $707K | $157K | $2.91M | $128K | $774K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $707K | $157K | $2.91M | $128K | $774K |
| Accounts Receivable | $37K | $306K | $205K | $0 | $0 |
| Inventory | $963K | $109K | $0 | $0 | $0 |
| Other Current Assets | $244K | $86K | $59.02M | $422K | -$794K |
| Total Current Assets | $1.95M | $956K | $62.9M | $606K | $179K |
| Long-Term Assets | |||||
| Property, Plant & Equipment Net | $402K | $499K | $1.02M | $1.11M | $1.35M |
| Goodwill | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $15K | $20K | $24K | $29K | $33K |
| Long-Term Investments | $0 | $0 | $0 | $156.69M | $154.45M |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | -$156.69M | -$154.45M |
| Total Long-Term Assets | $417K | $518K | $1.05M | $1.14M | $1.38M |
| Other Assets | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $2.37M | $1.47M | $63.95M | $1.75M | $1.56M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | $4.49M | $4.06M | $4.42M | $2.14M | $871K |
| Short-Term Debt | $95K | $241K | $1.29M | $2.78M | $8.6M |
| Current Income Tax Payable | $0 | $0 | $0 | $391K | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $1.39M | $2.37M |
| Other Current Liabilities | $7.82M | $0 | $31.35M | $349K | $1.96M |
| Total Current Liabilities | $7.92M | $5.88M | $38.5M | $7.3M | $15.8M |
| Long-Term Liabilities | |||||
| Long-Term Debt | $215K | $0 | $0 | $0 | $922 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $103K | $0 | $0 | $31.42M | $14.37M |
| Total Long-Term Liabilities | $318K | $310K | $698K | $32.24M | $15.33M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $8.23M | $6.19M | $39.2M | $39.54M | $31.13M |
| Stockholders' Equity | |||||
| Preferred Stock | $0 | $0 | $0 | $31.42M | $0 |
| Common Stock | $178 | $2K | $2K | $15K | $37K |
| Retained Earnings | -$75.78M | -$68.87M | -$58.5M | -$42.38M | -$32.77M |
| Comprehensive Income & Other | $0 | $0 | $0 | -$31.42M | $0 |
| Other Stockholders' Equity | $69.91M | $64.16M | $83.25M | $4.58M | $3.16M |
| Total Equity | -$5.87M | -$4.71M | $24.75M | -$37.79M | -$29.58M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $2.37M | $1.47M | $63.95M | $1.75M | $1.56M |
| Supplementary Data | |||||
| Total Debt | $310K | $639K | $2.14M | $3.74M | $9.69M |
| Net Debt | -$397K | $482K | -$776K | $3.61M | $8.91M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Operating Activities | |||||
| Net Income | -$6.91M | -$11.8M | -$15.45M | -$9.05M | -$6.48M |
| Depreciation & Amortization | $215K | $197K | $125K | $243K | $242K |
| Deferred Income Tax | $0 | $0 | $0 | -$195K | $2.52M |
| Stock-Based Compensation | $693K | $827K | $668K | $636K | $247K |
| Changes in Working Capital: | |||||
| Accounts Receivable | $44K | -$101K | -$205K | $0 | $0 |
| Inventory | $61K | -$109K | $205K | $0 | $0 |
| Accounts Payable | $127K | -$359K | -$450K | $1.06M | $80K |
| Other Working Capital | $0 | $1.24M | -$2.97M | $1.28M | $872K |
| Total Working Capital Change | $0 | $669K | -$3.42M | $2.34M | $953K |
| Other Non-Cash Items | $2.67M | $5.72M | $9.73M | $2.22M | $1.35M |
| Net Cash from Operating | -$3.33M | -$4.39M | -$8.35M | -$3.81M | -$1.18M |
| Investing Activities | |||||
| Capital Expenditures | -$14K | $0 | -$30K | -$7K | -$7K |
| Acquisitions | $0 | -$749K | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | -$154.44M |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | -$150K | $0 | $0 | $0 | $154.44M |
| Net Cash from Investing | -$164K | -$749K | -$30K | -$7K | -$7K |
| Financing Activities | |||||
| Debt Repaid | - | - | $1.86M | -$2.75M | -$1.12M |
| Common Stock Issuance | $3.48M | $2.69M | $41K | $0 | $3K |
| Common Stock Repurchases | $0 | $0 | $0 | -$2K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $4.04M | -$86K | $14.32M | $126K | $68K |
| Net Cash from Financing | $4.04M | $2.38M | $11.16M | $3.93M | $1.2M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $550K | -$2.76M | $2.78M | $116K | $11K |
| Supplementary Data | |||||
| Operating Cash Flow | -$3.33M | -$4.39M | -$8.35M | -$3.43M | -$1.18M |
| Capital Expenditure | -$14K | $0 | -$30K | -$7K | -$7K |
| Free Cash Flow | -$3.34M | -$4.39M | -$8.38M | -$3.44M | -$1.18M |
| Cash at Beginning | $157K | $2.91M | $128K | $12K | $1K |
| Cash at End | $707K | $157K | $2.91M | $128K | $12K |